Clinical governance benchmarking issues in oncology: Aggressiveness of cancer care and consumption of strong opioids. A single-center experience on measurement of quality of care

Tumori

Volumn 96, Issue 3, 2010, Pages 443-447

  Giovanis, Petros ^a   De Leonardis, Giovanni ^a   Garna, Antonella ^a   Lovat, Viviana ^a   Caldart, Francesca ^a   Quarta, Annarita ^a   Moretto, Laura ^a   Tuccia, Fausto ^a   Marcante, Marilisa ^a   Giusto, Mauro ^a  

^a Belluno City Hospital   (Italy)

Author keywords

Benchmarking issue; Palliative care; Quality of care

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CAPECITABINE; CARBOPLATIN; DOCETAXEL; EPIRUBICIN; ERLOTINIB; ETOPOSIDE; FENTANYL; FLUOROURACIL; FOTEMUSTINE; GEMCITABINE; HYDROMORPHONE; MORPHINE; MORPHINE SULFATE; NAVELBINE; OPIATE; OROS; OXALIPLATIN; OXYCODONE; PACLITAXEL; PEMETREXED; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; ADVANCED CANCER; AGED; ANALGESIA; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER OF UNKNOWN PRIMARY SITE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLEELAND PAIN MANAGEMENT INDEX; COLON CANCER; COLORECTAL CANCER; DEATH; DRUG FORMULATION; DRUG MEGADOSE; DRUG USE; FEMALE; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HEALTH CARE QUALITY; HEALTH SERVICES RESEARCH; HODGKIN DISEASE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; NONHODGKIN LYMPHOMA; ONCOLOGY; PAIN ASSESSMENT; PANCREAS CANCER; PATIENT CARE; PATIENT COMPLIANCE; PROGNOSIS; RATING SCALE; RETROSPECTIVE STUDY; SEPSIS; STOMACH CANCER; SUSTAINED DRUG RELEASE; TERMINAL CARE;

EID: 77954960334     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089161009600311     Document Type: Article

References (13)

1. Rowland J, Mariotto A, Aziz N, Tesauro G, Feuer EJ, Blackman D, Thompson P, Pollack LA: Cancer survivorship: United States, 1971-2001. MMWR, 53: 526-529, 2004.
2. Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC, Ayanian JZ: Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol, 26: 3860-3866, 2008.
3. National Cancer Policy Board: Ensuring Quality Cancer Care. Washington, DC, National Academy Press, 1999.
4. Emanuel EJ, Young-Xu Y, Levinsky NG, Gazelle G, Saynina O, Ash AS: Chemotherapy use among Medicare beneficiaries at the end of life. Ann Intern Med, 138: 636-643, 2003.
5. Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmueller S, Glare P, Nabal M, Viganò A, Larkin P, De Conno F, Hanks G, Kaasa S: Prognostic factors in advanced cancer patients: evidence-based clinical recommendations - a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol, 23: 6240-6248, 2005.
6. Stone PC, Lund S: Predicting prognosis in patients with advanced cancer. Ann Oncol, 18: 971-976, 2007.
7. Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, Pandya KJ: Pain and its treatment in outpatients withmetastatic cancer. N Engl JMed, 330: 592-596, 1994.
8. Deandrea S, Montanari M, Moja L, Apolone G: Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol, 19: 1985-1991, 2008.
9. Setoguchi S, Earle CC, Glynn R, Stedman M, Polinski JM, Corcoran CP, Haas JS: Comparison of prospective and retrospective indicators of the quality of end-of-life cancer care. J Clin Oncol, 26: 5671-5678, 2008.
10. Donabedian A: The quality of care: How can it be assessed? JAMA, 260: 1743-1748, 1988.
11. O'Brein M, Borthwick A, Rigg A, Leary A, Assersohn L, Last K, Tan S, Milan S, Tait D, Smith IE:Mortality within 30 days of chemotherapy: a clinical governance benchmarking issue for clinical oncology patients. Br J Cancer, 95: 1632-1636, 2006.
12. Matsuyama R, Reddy S, Smith TJ:Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death fromcancer. J Clin Oncol, 24: 3490-3496, 2006.
13. Mack JW, Wolfe J, Cook EF, Grier HE, Cleary PD, Weeks JC: Hope and prognostic disclosure. J Clin Oncol, 25: 5636-5642, 2007.